Literature DB >> 33185284

The Photosensitizing Efficacy of Micelles Containing a Porphyrinic Photosensitizer and KI against Resistant Melanoma Cells.

Kelly A D F Castro1,2, Letícia D Costa2, Juliana A Prandini1, Juliana C Biazzotto1, Augusto C Tomé2, Michael R Hamblin3, Maria da Graça P M S Neves2, M Amparo F Faustino2, Roberto S da Silva1.   

Abstract

Photodynamic therapy (PDT) is a promising alternative to overcome the resistance of melanoma to conventional therapies. Currently applied photosensitizers (PS) are often based on tetrapyrrolic macrocycles like porphyrins. Unfortunately, in some cases the use of this type of derivative is limited due to their poor solubility in the biological environment. Feasible approaches to surpass this drawback are based on lipid formulations. Besides that, and inspired in the efficacy of potassium iodide (KI) for antimicrobial photodynamic therapy (aPDT), the combined effect of singlet oxygen (1 O2 ) with KI was assessed in this work, as an alternative strategy to potentiate the effect of PDT against resistant melanoma cells.
© 2020 Wiley-VCH GmbH.

Entities:  

Keywords:  PDT; iodine; melanoma; porphyrin; singlet oxygen

Mesh:

Substances:

Year:  2021        PMID: 33185284      PMCID: PMC7921759          DOI: 10.1002/chem.202004389

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  39 in total

1.  Therapeutic and Aesthetic Uses of Photodynamic Therapy Part five of a five-part series: ALA-PDT and MAL-PDT What Makes Them Different.

Authors:  Michael H Gold
Journal:  J Clin Aesthet Dermatol       Date:  2009-02

2.  Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization.

Authors:  Ana P Castano; Tatiana N Demidova; Michael R Hamblin
Journal:  Photodiagnosis Photodyn Ther       Date:  2004-12       Impact factor: 3.631

3.  Photodynamic therapy of B16F10 murine melanoma with lutetium texaphyrin.

Authors:  K W Woodburn; Q Fan; D Kessel; Y Luo; S W Young
Journal:  J Invest Dermatol       Date:  1998-05       Impact factor: 8.551

Review 4.  An insight on the role of photosensitizer nanocarriers for Photodynamic Therapy.

Authors:  Mariana Q Mesquita; Cristina J Dias; Sara Gamelas; Margarida Fardilha; Maria G P M S Neves; Maria Amparo F Faustino
Journal:  An Acad Bras Cienc       Date:  2018       Impact factor: 1.753

Review 5.  Photodynamic therapy in oncology.

Authors:  Martijn Triesscheijn; Paul Baas; Jan H M Schellens; Fiona A Stewart
Journal:  Oncologist       Date:  2006-10

Review 6.  Antimicrobial photodynamic inactivation: a bright new technique to kill resistant microbes.

Authors:  Michael R Hamblin
Journal:  Curr Opin Microbiol       Date:  2016-07-13       Impact factor: 7.934

Review 7.  Photodynamic therapy.

Authors:  T J Dougherty; C J Gomer; B W Henderson; G Jori; D Kessel; M Korbelik; J Moan; Q Peng
Journal:  J Natl Cancer Inst       Date:  1998-06-17       Impact factor: 13.506

Review 8.  Dye Sensitizers for Photodynamic Therapy.

Authors:  Alexandra B Ormond; Harold S Freeman
Journal:  Materials (Basel)       Date:  2013-03-06       Impact factor: 3.623

9.  Photodynamic Therapy (PDT): PDT Mechanisms.

Authors:  Ron R Allison; Keyvan Moghissi
Journal:  Clin Endosc       Date:  2013-01-31

Review 10.  An updated overview on the development of new photosensitizers for anticancer photodynamic therapy.

Authors:  Juan Zhang; Chengshi Jiang; João Paulo Figueiró Longo; Ricardo Bentes Azevedo; Hua Zhang; Luis Alexandre Muehlmann
Journal:  Acta Pharm Sin B       Date:  2017-09-22       Impact factor: 11.413

View more
  2 in total

1.  Development of a Polymeric Film Entrapping Rose Bengal and Iodide Anion for the Light-Induced Generation and Release of Bactericidal Hydrogen Peroxide.

Authors:  Ana M López-Fernández; Evelina E Moisescu; Rosa de Llanos; Francisco Galindo
Journal:  Int J Mol Sci       Date:  2022-09-05       Impact factor: 6.208

Review 2.  Antimicrobial Photodynamic Therapy: Latest Developments with a Focus on Combinatory Strategies.

Authors:  Raphaëlle Youf; Max Müller; Ali Balasini; Franck Thétiot; Mareike Müller; Alizé Hascoët; Ulrich Jonas; Holger Schönherr; Gilles Lemercier; Tristan Montier; Tony Le Gall
Journal:  Pharmaceutics       Date:  2021-11-24       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.